Company: PCRX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001104659-25-041219
Chunk: 99

Company: Pacira BioSciences, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 99
---
 | ​ |
| All Current Directors Who Are Not Executive Officers as a Group                          | ​ | ​ | ​ | ​ |    483,837 | ​             | ​ |
| All Employees, Including All Current Officers Who Are Not Executive Officers, as a Group | ​ | ​ | ​ | ​ | 13,864,178 | ​             | ​ |

On April 1, 2025, the last reported sale price of our common stock at the close of business on the Nasdaq Global Select Market was $24.07 per share. (1) On January 16, 2025, Mr. Gaugler was named Executive Vice President, Commercial Operations, instead of his former title as Chief Operating Officer. ADMINISTRATION The A&R 2011 Plan is administered by our board. Our board has the authority to grant awards and adopt, amend, and repeal the administrative rules, guidelines and practices relating to the A&R 2011 Plan and to interpret the provisions of the A&R 2011 Plan and any award agreements entered into under the A&R 2011 Plan. Pursuant to the terms of the A&R 2011 Plan, our board may delegate authority under the A&R 2011 Plan to one or more committees or subcommittees of the board and may delegate the power to grant certain awards and such other authority under the A&R 2011 Plan as the board may determine to one or more of our officers. Our board has authorized our compensation committee to administer certain aspects of the A&R 2011 Plan, including the granting of options and RSUs to executive officers, and has authorized a committee of the board, consisting of our chief executive officer, to grant options and RSUs to non-executive employees, subject to limitations set by the compensation committee. Subject to any applicable limitations contained in the A&R 2011 Plan, our compensation committee selects the recipients of awards and determines:

104 | investor.pacira.com

TABLE OF CONTENTS Executive Compensation • the number of shares of our common stock covered by options and the dates upon which the options become exercisable; • the exercise price of options (which may not be less than 100%, or 110%, as applicable, of the fair market value of our common stock); • the duration of the options (which may not exceed 10 years, or five years, as applicable); and • the number of shares of our common stock subject to any SAR, award of restricted stock, RSU or other stock-based award and the terms